123 related articles for article (PubMed ID: 32812281)
1. High HMGA2 expression without gene rearrangement in meningiomas.
Nagaishi M; Nakae R; Matsumoto Y; Fujii Y; Sugiura Y; Takigawa T; Suzuki K
Neuropathology; 2020 Dec; 40(6):540-545. PubMed ID: 32812281
[TBL] [Abstract][Full Text] [Related]
2. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal and genetic aberrations differ with meningioma subtype.
Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2004; 21(3):127-33. PubMed ID: 15696974
[TBL] [Abstract][Full Text] [Related]
4. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
[TBL] [Abstract][Full Text] [Related]
5. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas.
Finelli P; Pierantoni GM; Giardino D; Losa M; Rodeschini O; Fedele M; Valtorta E; Mortini P; Croce CM; Larizza L; Fusco A
Cancer Res; 2002 Apr; 62(8):2398-405. PubMed ID: 11956103
[TBL] [Abstract][Full Text] [Related]
6. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.
Zaidi MR; Okada Y; Chada KK
Cancer Res; 2006 Aug; 66(15):7453-9. PubMed ID: 16885341
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
[TBL] [Abstract][Full Text] [Related]
9. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
[TBL] [Abstract][Full Text] [Related]
11. Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma.
Panagopoulos I; Bjerkehagen B; Gorunova L; Taksdal I; Heim S
Oncol Rep; 2015 Aug; 34(2):577-84. PubMed ID: 26043835
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
[TBL] [Abstract][Full Text] [Related]
13. The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups.
Domingues PH; Teodósio C; Otero Á; Sousa P; Gonçalves JM; Nieto AB; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
Neuropathol Appl Neurobiol; 2015 Apr; 41(3):319-32. PubMed ID: 24612434
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.
Wallesch M; Pachow D; Blücher C; Firsching R; Warnke JP; Braunsdorf WEK; Kirches E; Mawrin C
J Neurol Sci; 2017 Sep; 380():112-121. PubMed ID: 28870549
[TBL] [Abstract][Full Text] [Related]
15. Translocation (Y;12) in lipoma.
Liang CW; Mariño-Enríquez A; Johannessen C; Hornick JL; Dal Cin P
Cancer Genet; 2011 Jan; 204(1):53-6. PubMed ID: 21356192
[TBL] [Abstract][Full Text] [Related]
16. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
[TBL] [Abstract][Full Text] [Related]
17. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas.
Dahlén A; Mertens F; Rydholm A; Brosjö O; Wejde J; Mandahl N; Panagopoulos I
Mod Pathol; 2003 Nov; 16(11):1132-40. PubMed ID: 14614053
[TBL] [Abstract][Full Text] [Related]
18. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
19. A study of UbcH10 expression and its association with recurrence of meningiomas.
Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC
J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
